Soyoung Son
- Biomaterials top 2%
- Nanoparticle-Based Drug Delivery 11
- Pharmaceutical Science top 5%
- Advancements in Transdermal Drug Delivery 2
- Biomedical Engineering top 5%
- Nanoplatforms for cancer theranostics 15
- Molecular Medicine top 10%
- Cancer Research top 10%
- Cancer, Hypoxia, and Metabolism 3
-
- Extracellular vesicles in disease 8
- RNA Interference and Gene Delivery 4
-
- Immunotherapy and Immune Responses 5
-
- Cancer Immunotherapy and Biomarkers 3
Soyoung Son
22 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 83
- Biomaterials 537
- Pharmaceutical Science 94
- Biomedical Engineering 613
- Molecular Medicine 62
- Cancer Research 176
Countries citing papers authored by Soyoung Son
This map shows the geographic impact of Soyoung Son's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Soyoung Son with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Soyoung Son more than expected).
Fields of papers citing papers by Soyoung Son
This network shows the impact of papers produced by Soyoung Son. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Soyoung Son. The network helps show where Soyoung Son may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Soyoung Son, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 1 | |
| 3 | 2024 | 4 | |
| 4 | 2023 | 48 | |
| 5 | 2022 | 51 | |
| 6 | 2022 | 11 | |
| 7 | 2021 | 27 | |
| 8 | 2021 | 66 | |
| 9 | 2021 | 50 | |
| 10 | 2018 | 26 | |
| 11 | 2017 | 57 | |
| 12 | 2017 | 55 | |
| 13 | 2016 | 19 | |
| 14 | 2016 | 27 | |
| 15 | 2015 | 78 | |
| 16 | 2015 | 81 | |
| 17 | 2015 | 21 | |
| 18 | 2013 | 72 | |
| 19 | 2013 | 297 | |
| 20 | 2001 | 1 |
About Soyoung Son
Soyoung Son is a scholar working on Biomaterials, Biomedical Engineering and Immunology, having authored 23 papers that have together received 1.2k indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (15 papers), Nanoparticle-Based Drug Delivery (11 papers), Extracellular vesicles in disease (8 papers), Immunotherapy and Immune Responses (5 papers), RNA Interference and Gene Delivery (4 papers), Cancer, Hypoxia, and Metabolism (3 papers), Cancer Immunotherapy and Biomarkers (3 papers) and Advancements in Transdermal Drug Delivery (2 papers). The work is most often cited by research in Biomaterials (537 citations), Pharmaceutical Science (94 citations) and Biomedical Engineering (613 citations). Soyoung Son has collaborated with scholars based in South Korea and United States. Frequent co-authors include Jae Hyung Park, Hyewon Ko, Thavasyappan Thambi, Hwa Seung Han, Dong‐Gyu Jo, Doo Sung Lee, Sol Shin, V. G. Deepagan, Hong Yeol Yoon and Kwangmeyung Kim. Their work appears in journals such as Biomaterials, Acta Biomaterialia, International Journal of Biological Macromolecules, Journal of Biomedical Materials Research Part B Applied Biomaterials and Chemistry of Materials.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.